Hackensack Meridian Health - Center for Discovery and Innovation
Nutley, New Jersey, 07110, United States
Completed
NCT Number: NCT05824273
The INSPIRE-Lung Study
LungTalk and leveraging Facebook-targeted Advertisement (FBTA) addresses the call to develop and test multi-level, cancer communication interventions using innovative methods and designs. The study's long term goal is to increase lung cancer screening uptake among appropriate, high-risk individuals nationwide.
Completed
Looking for future studies?
Notify MeKey information
Conditions
Age range
50 year–80 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- ≥20-pack-year smoking history;
- Individuals who currently smoke or quit smoking within the past 15 years
Exclusion criteria
- Previously undergone LDCT for early detection of lung cancer, have a lung nodule or nodules that are currently being followed
- Has ever been diagnosed with lung cancer
- Individuals with impaired decision-making (because our primary outcome is decision-making, we will not include individuals with impaired decision-making)
Treatment and study plan
LungTalk
BehavioralLungTalk is a 10-15 minute long computer-tailored health communication and decision-making tool.
Non-tailored intervention - Standard of practice
BehavioralACS Lung Screening Informational Video
Primary outcomes
-
Reaching Screening Eligible Individuals Via Social Media - Reach
Time frame: 11-month period ad remained active on Facebook
Leveraging a well-established, social media-based platform (Facebook) to target screening-eligible individuals in the community. This will be measured by the total number of people who saw the FBTA at least once.
-
Reaching Screening Eligible Individuals Via Social Media - Link Clicks
Time frame: 11-month period ad remained active on Facebook
Leveraging a well-established, social media-based platform (Facebook) to target screening-eligible individuals in the community. This will be measured by the total number of clicks on the link within the FBTA that led to the REDCap survey platform of the study.
-
Reaching Screening Eligible Individuals Via Social Media - Impressions
Time frame: 11-month period ad remained active on Facebook
Leveraging a well-established, social media-based platform (Facebook) to target screening-eligible individuals in the community. This will be measured by the total number of times the FBTA was on screen (may include multiple views of the ad by the same person/people).
-
Effectiveness of LungTalk - Knowledge Assessment
Time frame: At baseline
The assessment plan is intended to compare the effectiveness of a tailored (LungTalk) versus non-tailored health communication and decision support tool delivered online to improve total knowledge about lung screening. The total Knowledge of Lung Cancer Screening will be assessed with a 9-item multidimensional scale ranging from 0 to 9 with 0 being "No Knowledge" and 9 being "Complete knowledge".
-
Effectiveness of LungTalk - Knowledge Assessment
Time frame: At one week from baseline survey completion
The assessment plan is intended to compare the effectiveness of a tailored (LungTalk) versus non-tailored health communication and decision support tool delivered online to improve total knowledge about lung screening. The total Knowledge of Lung Cancer Screening will be assessed with a 9-item multidimensional scale ranging from 0 to 9 with 0 being "No Knowledge" and 9 being "Complete knowledge".
-
Effectiveness of LungTalk - Perceived Risk
Time frame: At baseline
The assessment plan is intended to compare the effectiveness of a tailored (LungTalk) versus non-tailored health communication and decision support tool delivered online to improve Perceived Risk. Perceived Risk of Lung Cancer is a 3-item scale with Likert-type responses. The range of scores is 3 to 12 (higher perceived risk of lung cancer).
-
Effectiveness of LungTalk - Perceived Risk
Time frame: At one week from baseline survey completion
The assessment plan is intended to compare the effectiveness of a tailored (LungTalk) versus non-tailored health communication and decision support tool delivered online to improve Perceived Risk. Perceived Risk of Lung Cancer is a 3-item scale with Likert-type responses. The range of scores is 3 to 12 (higher perceived risk of lung cancer).
-
Effectiveness of LungTalk - Perceived Benefits
Time frame: At baseline
The assessment plan is intended to compare the effectiveness of a tailored (LungTalk) versus non-tailored health communication and decision support tool delivered online to improve Perceived Benefits. Perceived Benefits of Lung Cancer Screening is a 6-item scale with responses ranging from 1=strongly disagree to 4=strongly agree. The range of scores is 6 to 24 (higher perceived benefits).
-
Effectiveness of LungTalk - Perceived Benefits
Time frame: At one week from baseline survey completion
The assessment plan is intended to compare the effectiveness of a tailored (LungTalk) versus non-tailored health communication and decision support tool delivered online to improve Perceived Benefits. Perceived Benefits of Lung Cancer Screening is a 6-item scale with responses ranging from 1=strongly disagree to 4=strongly agree. The range of scores is 6 to 24 (higher perceived benefits).
-
Effectiveness of LungTalk - Perceived Barriers
Time frame: At baseline
The assessment plan is intended to compare the effectiveness of a tailored (LungTalk) versus non-tailored health communication and decision support tool delivered online to improve Perceived Barriers. Perceived Barriers to Lung Cancer Screening. This scale has 17 items with four-point Likert responses where 1=strongly disagree and 4=strongly agree. The range of scores is 17 to 68 (higher perceived barriers).
-
Effectiveness of LungTalk - Perceived Barriers
Time frame: At one week from baseline survey completion
The assessment plan is intended to compare the effectiveness of a tailored (LungTalk) versus non-tailored health communication and decision support tool delivered online to improve Perceived Barriers. Perceived Barriers to Lung Cancer Screening. This scale has 17 items with four-point Likert responses where 1=strongly disagree and 4=strongly agree. The range of scores is 17 to 68 (higher perceived barriers).
-
Effectiveness of LungTalk - Self-Efficacy
Time frame: At baseline
The assessment plan is intended to compare the effectiveness of a tailored (LungTalk) versus non-tailored health communication and decision support tool delivered online to improve Self-Efficacy. Self-Efficacy for Lung Cancer Screening will be assessed using a scale with nine items with a four-point Likert response option to assess individual beliefs about ability to arrange and complete a low-dose computed tomography (LDCT) to screen for lung cancer. The range of scores is 9 to 36 (higher levels of self-efficacy).
-
Effectiveness of LungTalk - Self-Efficacy
Time frame: At one week from baseline survey completion
The assessment plan is intended to compare the effectiveness of a tailored (LungTalk) versus non-tailored health communication and decision support tool delivered online to improve Self-Efficacy. Self-Efficacy for Lung Cancer Screening will be assessed using a scale with nine items with a four-point Likert response option to assess individual beliefs about ability to arrange and complete a low-dose computed tomography (LDCT) to screen for lung cancer. The range of scores is 9 to 36 (higher levels of self-efficacy).
-
Effectiveness of LungTalk - Occurrence of a Patient-Clinician Discussion
Time frame: At baseline
The assessment plan is intended to compare the effectiveness of a tailored (LungTalk) versus non-tailored health communication and decision support tool delivered online to improve Occurrence of a Patient-Clinician Discussion. Occurrence of a Patient-Clinician Discussion about Lung Cancer Screening will be assessed with a single item requiring dichotomous (Y/N) response regarding a discussion with their healthcare provider.
-
Effectiveness of LungTalk - Occurrence of a Patient-Clinician Discussion
Time frame: At one week from baseline survey completion
The assessment plan is intended to compare the effectiveness of a tailored (LungTalk) versus non-tailored health communication and decision support tool delivered online to improve Occurrence of a Patient-Clinician Discussion. Occurrence of a Patient-Clinician Discussion about Lung Cancer Screening will be assessed with a single item requiring dichotomous (Y/N) response regarding a discussion with their healthcare provider.
-
Effectiveness of LungTalk - Occurrence of a Patient-Clinician Discussion
Time frame: At 6 months from baseline survey completion
The assessment plan is intended to compare the effectiveness of a tailored (LungTalk) versus non-tailored health communication and decision support tool delivered online to improve Occurrence of a Patient-Clinician Discussion. Occurrence of a Patient-Clinician Discussion about Lung Cancer Screening will be assessed with a single item requiring dichotomous (Y/N) response regarding a discussion with their healthcare provider.
-
Effectiveness of LungTalk - Screening Uptake
Time frame: At baseline
The assessment plan is intended to compare the effectiveness of a tailored (LungTalk) versus non-tailored health communication and decision support tool delivered online to improve Screening Uptake, Lung Cancer Screening Uptake will be assessed via self-report via the stages of adoption algorithm for lung screening. There are seven stages (unaware, aware but unengaged, undecided, decided not to act, decided to act, action, and maintenance).
-
Effectiveness of LungTalk - Screening Uptake
Time frame: At one week from baseline survey completion
The assessment plan is intended to compare the effectiveness of a tailored (LungTalk) versus non-tailored health communication and decision support tool delivered online to improve Screening Uptake, Lung Cancer Screening Uptake will be assessed via self-report via the stages of adoption algorithm for lung screening. There are seven stages (unaware, aware but unengaged, undecided, decided not to act, decided to act, action, and maintenance).
-
Effectiveness of LungTalk - Screening Uptake
Time frame: At 6 months from baseline survey completion
The assessment plan is intended to compare the effectiveness of a tailored (LungTalk) versus non-tailored health communication and decision support tool delivered online to improve Screening Uptake, Lung Cancer Screening Uptake will be assessed via self-report via the stages of adoption algorithm for lung screening. There are seven stages (unaware, aware but unengaged, undecided, decided not to act, decided to act, action, and maintenance).
Sponsors and collaborators
Lead sponsor
Hackensack Meridian Health
Other
Collaborators
- National Cancer Institute (NCI)
Registry information
Official study title
Leveraging Social Media to Increase Lung Cancer Screening Awareness, Knowledge and Uptake in High-Risk Populations
Important dates
- Study start
- 2023
- Primary completion
- 2024
- Study completion
- 2024
- First posted
- Apr 21, 2023
- Registry last updated
- Nov 21, 2025
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Completed
Development of a Biologic Specimen Bank for the Study of Early Markers of Lung Cancer Among Tin Miners in Yunnan, China
NCT00340405
Lung Cancer, Lung Diseases
Beijing, China
View Trial Details
Completed
Modulation of Anti-tumor T Cell Responses in Cancer Patients Treated by Concomitant Radiochemotherapy
NCT03117946
Head and Neck Cancer, Head and Neck Neoplasms
Besançon, France
View Trial Details
Completed
Increasing Adherence to Lung Cancer Screening
NCT05832008
Adherence, Patient, Behavior
Philadelphia, Pennsylvania, United States
View Trial Details
Completed
Assessment of Diagnostic Yield Using a Robotic Navigational Bronchoscopy System With CBCT
NCT06084208
Lung Cancer, Lung Diseases
Nijmegen, Netherlands
View Trial Details